Former Superintendent of NTUH; Professor Emeritus at NTU; ITRI Laureate; Decades of experiences in cardiovascular research, clinical medicine and healthcare administration
Chairman of E.SUN FHC and E.SUN Commercial Bank; leading E.SUN to be listed in Dow Jones Sustainability Emerging Markets Index since 2014 as the company with the best performance in Taiwan's financial industry
CEO & President, Rock BioTherapeutics;
Professor Emeritus, Harvard Medical School; Academician in Taiwan; Founder of multiple biotech ventures, including Fuji ImmunoPharmaceuticals, Shionogi BioResearch, Caxton Life Science Partners, TaiMed Biologics, Synta Pharmaceuticals and Sequential Medicine
SVP, Rock BioMedical;
Former CSO, AB Biosciences; Former Deputy Director, Harvard Gene Therapy Initiative;
25+ yrs in Biologics R&D; 14+ yr industry experiences including venture building, management & leadership, deal making with Pharma
Associate Professor, Department of
Finance and Banking, Aletheia University;
Independent Director of E.SUN Bank(China)
and Independent Director of Union
Commercial Bank PLC.(Cambodia)
